HilleVax (HLVX) Competitors $2.09 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.09 0.00 (0.00%) As of 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HLVX vs. KMDA, CGEM, AURA, PRTC, FULC, SLDB, YMAB, MBX, IMAB, and DMACShould you be buying HilleVax stock or one of its competitors? The main competitors of HilleVax include Kamada (KMDA), Cullinan Therapeutics (CGEM), Aura Biosciences (AURA), PureTech Health (PRTC), Fulcrum Therapeutics (FULC), Solid Biosciences (SLDB), Y-mAbs Therapeutics (YMAB), MBX Biosciences (MBX), I-Mab (IMAB), and DiaMedica Therapeutics (DMAC). These companies are all part of the "pharmaceutical products" industry. HilleVax vs. Its Competitors Kamada Cullinan Therapeutics Aura Biosciences PureTech Health Fulcrum Therapeutics Solid Biosciences Y-mAbs Therapeutics MBX Biosciences I-Mab DiaMedica Therapeutics Kamada (NASDAQ:KMDA) and HilleVax (NASDAQ:HLVX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk and media sentiment. Which has better valuation & earnings, KMDA or HLVX? Kamada has higher revenue and earnings than HilleVax. HilleVax is trading at a lower price-to-earnings ratio than Kamada, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKamada$169.52M2.38$14.46M$0.3420.65HilleVaxN/AN/A-$147.27M-$1.43-1.46 Is KMDA or HLVX more profitable? Kamada has a net margin of 11.22% compared to HilleVax's net margin of 0.00%. Kamada's return on equity of 7.41% beat HilleVax's return on equity.Company Net Margins Return on Equity Return on Assets Kamada11.22% 7.41% 5.18% HilleVax N/A -34.29%-28.50% Does the media favor KMDA or HLVX? In the previous week, Kamada had 2 more articles in the media than HilleVax. MarketBeat recorded 4 mentions for Kamada and 2 mentions for HilleVax. Kamada's average media sentiment score of 1.47 beat HilleVax's score of 0.45 indicating that Kamada is being referred to more favorably in the media. Company Overall Sentiment Kamada Positive HilleVax Neutral Do institutionals & insiders believe in KMDA or HLVX? 20.4% of Kamada shares are held by institutional investors. Comparatively, 86.4% of HilleVax shares are held by institutional investors. 36.1% of Kamada shares are held by company insiders. Comparatively, 24.9% of HilleVax shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, KMDA or HLVX? Kamada has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, HilleVax has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Do analysts rate KMDA or HLVX? Kamada presently has a consensus target price of $13.00, indicating a potential upside of 85.19%. HilleVax has a consensus target price of $2.00, indicating a potential downside of 4.31%. Given Kamada's stronger consensus rating and higher possible upside, analysts clearly believe Kamada is more favorable than HilleVax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kamada 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67HilleVax 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryKamada beats HilleVax on 14 of the 15 factors compared between the two stocks. Get HilleVax News Delivered to You Automatically Sign up to receive the latest news and ratings for HLVX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HLVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HLVX vs. The Competition Export to ExcelMetricHilleVaxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$104.79M$3.13B$5.79B$10.15BDividend YieldN/A2.32%5.69%4.60%P/E Ratio-1.4621.3074.5925.92Price / SalesN/A257.21453.5485.33Price / CashN/A45.3337.0859.91Price / Book0.679.6112.156.29Net Income-$147.27M-$53.29M$3.28B$270.77M7 Day Performance-0.48%0.28%0.99%3.36%1 Month Performance1.46%8.91%7.21%6.41%1 Year Performance20.81%13.14%63.07%28.24% HilleVax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HLVXHilleVax1.5972 of 5 stars$2.09flat$2.00-4.3%+22.2%$104.79MN/A-1.4620Positive NewsShort Interest ↑High Trading VolumeKMDAKamada4.5423 of 5 stars$7.19-0.5%$13.00+80.9%+33.3%$413.17M$169.52M21.13360Positive NewsShort Interest ↓CGEMCullinan Therapeutics2.2492 of 5 stars$6.92+1.2%$26.80+287.3%-63.2%$409.24MN/A-2.1430News CoveragePositive NewsAnalyst ForecastAURAAura Biosciences2.2575 of 5 stars$6.47flat$22.00+240.0%-26.8%$402.29MN/A-3.3050PRTCPureTech Health0.5624 of 5 stars$16.61+1.1%N/A-18.0%$400.83M$6.17M0.00100Short Interest ↑FULCFulcrum Therapeutics2.6564 of 5 stars$7.31+0.6%$7.57+3.6%-21.0%$395.40M$80M-5.99100Positive NewsShort Interest ↓SLDBSolid Biosciences2.9954 of 5 stars$5.02-2.1%$15.00+198.8%-29.1%$391.30M$8.09M-1.79100Positive NewsYMABY-mAbs Therapeutics2.0783 of 5 stars$8.59-0.1%$9.62+12.1%-35.3%$390.10M$87.68M-17.17150News CoveragePositive NewsMBXMBX Biosciences0.1296 of 5 stars$11.35+4.1%N/AN/A$381.29MN/A-2.50N/AIMABI-Mab2.8108 of 5 stars$4.57+7.0%$7.00+53.2%+264.5%$373.27M$3.89M0.00380Analyst ForecastDMACDiaMedica Therapeutics2.2352 of 5 stars$7.16flat$12.33+72.3%+66.2%$372.17MN/A-10.4320Analyst Upgrade Related Companies and Tools Related Companies KMDA Competitors CGEM Competitors AURA Competitors PRTC Competitors FULC Competitors SLDB Competitors YMAB Competitors MBX Competitors IMAB Competitors DMAC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HLVX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HilleVax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HilleVax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HLVX Stock Alerts